glp-1 news today october 16 2025 Alarming rise in weight loss drug overdoses The New Health Consumer Mindset

Explore comprehensive weight and wellness treatment options from DrWell's trusted providers

Do not apply heat directly over the patch

Tackling multiple diseases with a single prescription, making GLP-1s a disruptor in todays medical landscape

Long-acting glucagon-like peptide (GLP)-1 analogs are currently available in treating diabetes with widely established safety and extensively evaluated efficacy

At $16, Hims & Hers Health stock is cheap on sales metrics, but upside is capped pending regulatory clarity and proof of profit pool rebuild

Thanks to biochemical engineering, the glucagon-like peptide-1 (GLP-1) molecule has emerged as an